Inventor · disambiguated record
Stacey Shepard
Also filed as: SHEPARD STACEY
58 granted patents·19 pending applications·2,323 citations·filing 2005–2025
99Inventor score
Top patents by PatentIndex Score
77 records- 0199US11331320B2Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitorsINCYTE CORP·Filed 2020·Granted May 17, 2022·12 cites·21 claims
- 0299US10639310B2Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitorsINCYTE CORP·Filed 2018·Granted May 5, 2020·20 cites·6 claims
- 0399US10398699B2Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitorsINCYTE CORP·Filed 2018·Granted Sep 3, 2019·31 cites·7 claims
- 0499US9974790B2Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as janus kinase inhibitorsINCYTE CORP·Filed 2016·Granted May 22, 2018·40 cites·14 claims
- 0599US9079912B2Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as Janus kinase inhibitorsINCYTE CORP·Filed 2014·Granted Jul 14, 2015·75 cites·6 claims
- 0699US8530485B2Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitorsRODGERS JAMES D·Filed 2011·Granted Sep 10, 2013·98 cites·10 claims
- 0799US8158616B2Azetidine and cyclobutane derivatives as JAK inhibitorsRODGERS JAMES D·Filed 2009·Granted Apr 17, 2012·170 cites·3 claims
- 0899US7598257B2Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitorsINCYTE CORP·Filed 2006·Granted Oct 6, 2009·328 cites·8 claims
- 0998US9662335B2Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as janus kinase inhibitorsINCYTE CORP·Filed 2016·Granted May 30, 2017·25 cites·6 claims
- 1098US8946245B2Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitorsRODGERS JAMES D·Filed 2011·Granted Feb 3, 2015·70 cites·26 claims
- 1198US8933086B2Heteroaryl substituted pyrrolo[2,3-B]pyridines and pyrrolo[2,3-B]pyrimidines as Janus kinase inhibitorsINCYTE CORP·Filed 2013·Granted Jan 13, 2015·71 cites·7 claims
- 1298US8933085B2Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitorsRODGERS JAMES D·Filed 2011·Granted Jan 13, 2015·96 cites·39 claims
- 1398US8716303B2N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitorsRODGERS JAMES D·Filed 2010·Granted May 6, 2014·109 cites·74 claims
- 1498US8541425B2Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitorsRODGERS JAMES D·Filed 2009·Granted Sep 24, 2013·92 cites·7 claims
- 1598US8420629B2Azetidine and cyclobutane derivatives as JAK inhibitorsRODGERS JAMES D·Filed 2011·Granted Apr 16, 2013·105 cites·2 claims
- 1698US8415362B2Pyrazolyl substituted pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitorsRODGERS JAMES D·Filed 2008·Granted Apr 9, 2013·117 cites·21 claims
- 1797US10138248B2Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-b]pyridazines and substituted imidazo[1,2-a]pyrazines as PI3K-γ inhibitorsINCYTE CORP·Filed 2017·Granted Nov 27, 2018·36 cites·24 claims
- 1897US10065963B2Heterocyclic compounds as PI3K-γ inhibitorsINCYTE CORP·Filed 2016·Granted Sep 4, 2018·16 cites·14 claims
- 1997US9334274B2N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitorsINCYTE CORP·Filed 2014·Granted May 10, 2016·57 cites·34 claims
- 2097US9206187B2Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as Janus kinaseINCYTE CORP·Filed 2013·Granted Dec 8, 2015·55 cites·26 claims
- 2197US8889697B2Metabolites of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrileRODGERS JAMES D·Filed 2010·Granted Nov 18, 2014·79 cites·6 claims
- 2296US10472368B2Heterocyclic compounds as PI3K-γ inhibitorsINCYTE CORP·Filed 2018·Granted Nov 12, 2019·12 cites·28 claims
- 2396US9814722B2Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as janus kinase inhibitorsINCYTE CORP·Filed 2016·Granted Nov 14, 2017·13 cites·30 claims
- 2496US9777003B2Tricyclic heterocycles as bet protein inhibitorsINCYTE CORP·Filed 2016·Granted Oct 3, 2017·25 cites·24 claims
- 2596US9309246B2Tricyclic heterocycles as BET protein inhibitorsINCYTE CORP·Filed 2014·Granted Apr 12, 2016·33 cites·32 claims
- 2696US9249145B2Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitorsRODGERS JAMES D·Filed 2010·Granted Feb 2, 2016·45 cites·56 claims
- 2796US8748401B2Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrileRODGERS JAMES D·Filed 2013·Granted Jun 10, 2014·80 cites·11 claims
- 2896US8486902B2Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H-pyrrolo[2,3-d] pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrileRODGERS JAMES D·Filed 2010·Granted Jul 16, 2013·125 cites·14 claims
- 2995US11926616B2Aminopyrazine diol compounds as PI3K-γ inhibitorsINCYTE CORP·Filed 2021·Granted Mar 12, 2024·2 cites·30 claims
- 3095US11225486B2Tertiary alcohols as PI3K-γ inhibitorsINCYTE CORP·Filed 2020·Granted Jan 18, 2022·4 cites·51 claims
- 3195US11091484B2Tricyclic heterocycles as BET protein inhibitorsINCYTE CORP·Filed 2019·Granted Aug 17, 2021·8 cites·21 claims
- 3295US10640506B2Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidines derivatives as JAK inhibitorsINCYTE CORP·Filed 2018·Granted May 5, 2020·19 cites·20 claims
- 3395US10442803B2Tricyclic heterocycles as bet protein inhibitorsINCYTE CORP·Filed 2017·Granted Oct 15, 2019·17 cites·29 claims
- 3495US7834022B2Metabolites of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrileINCYTE CORP·Filed 2008·Granted Nov 16, 2010·141 cites·11 claims
- 3594US9193733B2Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitorsINCYTE CORP·Filed 2013·Granted Nov 24, 2015·33 cites·48 claims
- 3693US11926630B2Tertiary alcohols as PI3K-γ inhibitorsINCYTE CORP·Filed 2021·Granted Mar 12, 2024·2 cites·2 claims
- 3793US10975088B2Imidazo[2,1-f][1,2,4]triazine compounds as pi3k-y inhibitorsINCYTE CORP·Filed 2019·Granted Apr 13, 2021·6 cites·13 claims
- 3893US10479795B2Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines and substituted imidazo[1,2-b]pyridazines as PI3K-gamma inhibitorsINCYTE CORP·Filed 2018·Granted Nov 19, 2019·13 cites·45 claims
- 3992US10463667B2Metabolites of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrileINCYTE CORP·Filed 2017·Granted Nov 5, 2019·5 cites·26 claims
- 4090US11046658B2Aminopyrazine derivatives as PI3K-γ inhibitorsINCYTE CORP·Filed 2019·Granted Jun 29, 2021·4 cites·23 claims
- 4188US10738057B2Tertiary alcohols as PI3K-γ inhibitorsINCYTE CORP·Filed 2018·Granted Aug 11, 2020·5 cites·38 claims
- 4287US12365668B2Aminopyrazine diol compounds as PI3K-y inhibitorsINCYTE CORP·Filed 2024·Granted Jul 22, 2025·0 cites·17 claims
- 4387US11161838B2Heterocyclic derivatives as PI3K inhibitorsINCYTE CORP·Filed 2019·Granted Nov 2, 2021·4 cites·39 claims
- 4487US10669262B2Aminopyrazine diol compounds as PI3K-γ inhibitorsINCYTE CORP·Filed 2019·Granted Jun 2, 2020·4 cites·41 claims
- 4587US9512161B2Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrileINCYTE CORP·Filed 2014·Granted Dec 6, 2016·9 cites·6 claims
- 4686US11691971B2Naphthyridinone compounds as JAK2 V617F inhibitorsINCYTE CORP·Filed 2021·Granted Jul 4, 2023·1 cites·46 claims
- 4786US11091491B2Heterocyclic compounds as PI3K-y inhibitorsINCYTE CORP·Filed 2019·Granted Aug 17, 2021·4 cites·37 claims
- 4885US11958861B2Spirocyclic lactams as JAK2 V617F inhibitorsINCYTE CORP·Filed 2022·Granted Apr 16, 2024·1 cites·61 claims
- 4985US11744832B2Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitorsINCYTE CORP·Filed 2022·Granted Sep 5, 2023·0 cites·11 claims
- 5085US2025313550A1AMINOPYRAZINE DIOL COMPOUNDS AS PI3K-y INHIBITORSINCYTE CORP·Filed 2025·Application pending·0 cites
Showing the top 50 of 77 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Stacey Shepard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →